Product Details:
Strength | 150 mg + 100 mg |
Packaging Size | 3 x 10 Tablets |
Composition | Nirmatrelvir (150mg) + Ritonavir (100mg) |
Treatment | Coronavirus disease (COVID-19) |
Brand | Paxobrooks |
Country of Origin | Made in India |
Paxobrook Tablets is intended to treat mild-to-moderate coronavirus disease(COVID-19) in adults and children aged 12 years and older weighing at least 40 kg with a positive COVID-19 test and at risk of progression to severe disease. It reduces the ability of the coronavirus to multiply in the body.